Molecular mechanisms in the dramatic enhancement of HIV-1 Tat transduction by cationic liposomes

FASEB Journal

Volumn 26, Issue 7, 2012, Pages 2824-2834

  Li, Guan Han ^a,b   Li, Wenxue ^a,b   Mumper, Russell J ^c   Nath, Avindra ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Endocytosis; Hydrophobic peptide; Intracellular delivery; Transactivation; Uptake

Indexed keywords

CATION; CELL PENETRATING PEPTIDE; FLUORESCENT DYE; LIPOSOME; TRANSACTIVATOR PROTEIN;

ACTIN FILAMENT; ARTICLE; CELL MIGRATION; CLINICAL PHARMACOLOGY; CONTROLLED STUDY; DRUG MECHANISM; ENDOCYTOSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROPHOBICITY; INTRACELLULAR MEMBRANE; LONG TERMINAL REPEAT; MEMBRANE BINDING; MICROSCOPY; NONHUMAN; PINOCYTOSIS; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN LOCALIZATION; TRANSACTIVATION; VIRAL GENE DELIVERY SYSTEM;

ACTIN CYTOSKELETON; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; CATIONS; CELL LINE; ENDOCYTOSIS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LIPOSOMES; MEMBRANE MICRODOMAINS; PINOCYTOSIS; PROTEIN TRANSPORT; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRANSCRIPTIONAL ACTIVATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84863192614     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.11-203315     Document Type: Article

References (73)

1. Rana, T. M., and Jeang, K. T. (1999) Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA. Arch. Biochem. Biophys. 365, 175-185 (Pubitemid 29391624)
2. Stauber, R. H., and Pavlakis, G. N. (1998) Intracellular trafficking and interactions of the HIV-1 Tat protein. Virology 252, 126-136 (Pubitemid 28564139)
3. Jones, K. A., and Peterlin, B. M. (1994) Control of RNA initiation and elongation at the HIV-1 promoter. Ann. Rev. Biochem. 63, 717-743 (Pubitemid 24218647)
4. Bilodeau, P. S., Domsic, J. K., and Stoltzfus, C. M. (1999) Splicing regulatory elements within tat exon 2 of human immunodeficiency virus type 1 (HIV-1) are characteristic of group M but not group O HIV-1 strains. J. Virol. 73, 9764-9772
5. Rosen, C. A., Terwilliger, E., Dayton, A., Sodroski, J. G., and Haseltine, W. A. (1988) Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus. Proc. Natl. Acad. Sci. U. S. A. 85, 2071-2075 (Pubitemid 24315830)
6. Liu, Y., Wang, Z., and Rana, T. M. (1996) Visualizing a specific contact in the HIV-1 Tat protein fragment and trans-activation responsive region RNA complex by photocross-linking. J. Biol. Chem. 271, 10391-10396 (Pubitemid 26131605)
7. Ruben, S., Perkins, A., Purcell, R., Joung, K., Sia, R., Burghoff, R., Haseltine, W. A., and Rosen, C. A. (1989) Structural and functional characterization of human immunodeficiency virus Tat protein. J. Virol. 63, 1-8 (Pubitemid 19028076)
8. Kuppuswamy, M., Subramanian, T., Srinivasan, A., and Chinnadurai, G. (1989) Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis. Nucl. Acids Res. 17, 3551-3561 (Pubitemid 19120452)
9. Jeang, K. T., Xiao, H., and Rich, E. A. (1999) Multifaceted activities of the HIV-1 transactivator of transcription, Tat. J. Biol. Chem. 274, 28837-28840
10. Subramanian, T., Kuppuswamy, M., Venkatesh, L., Srinivasan, A., and Chinnadurai, G. (1990) Functional substitution of the basic domain of the HIV-1 trans-activator, Tat, with the basic domain of the functionally heterologous Rev. Virology 176, 178-183 (Pubitemid 20149680)
11. Ensoli, B., Barillari, G., Salahuddin, S. Z., Gallo, R. C., and Wong-Staal, F. (1990) Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345, 84-86
12. Ensoli, B., Buonaguro, L., Barillari, G., Fiorelli, V., Gendelman, R., Morgan, R. A., Wingfield, P., and Gallo, R. C. (1993) Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67, 277-287 (Pubitemid 23002988)
13. Turchan, J., Anderson, C., Hauser, K. F., Sun, Q., Zhang, J., Liu, Y., Wise, P. M., Kruman, I., Maragos, W., Mattson, M. P., Booze, R., and Nath, A. (2001) Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine. BMC Neurosci. 2, 3
14. Johnston, J. B., Zhang, K., Silva, C., Shalinsky, D. R., Conant, K., Ni, W., Corbett, D., Yong, V. W., and Power, C. (2001) HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors. Ann. Neurol. 49, 230-241 (Pubitemid 32157999)
15. Chauhan, A., Turchan, J., Pocernich, C., Bruce-Keller, A., Roth, S., Butterfield, D. A., Major, E. O., and Nath, A. (2003) Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport. J. Biol. Chem. 278, 13512-13519 (Pubitemid 36800126)
16. Chang, H. C., Samaniego, F., Nair, B. C., Buonaguro, L., and Ensoli, B. (1997) HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. AIDS 11, 1421-1431 (Pubitemid 27421173)
17. Rayne, F., Debaisieux, S., Yezid, H., Lin, Y. L., Mettling, C., Konate, K., Chazal, N., Arold, S. T., Pugniere, M., Sanchez, F., Bonhoure, A., Briant, L., Loret, E., Roy, C., and Beaumelle, B. (2010) Phosphatidylinositol-(4,5)- bisphosphate enables efficient secretion of HIV-1 Tat by infected T-cells. EMBO J. 29, 1348-1362
18. Rayne, F., Debaisieux, S., Bonhoure, A., and Beaumelle, B. (2010) HIV-1 Tat is unconventionally secreted through the plasma membrane. Cell Biol. Internat. 34, 409-413
19. Frankel, A. D., and Pabo, C. O. (1988) Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55, 1189-1193 (Pubitemid 19020071)
20. Vives, E. (2003) Cellular uptake [correction of utake] of the Tat peptide: an endocytosis mechanism following ionic interactions. J. Mol. Recognit. 16, 265-271
21. Debaisieux, S., Rayne, F., Yezid, H., and Beaumelle, B. (2012) The ins and outs of HIV-1 Tat. Traffic 13, 355-363
22. Belting, M. (2003) Heparan sulfate proteoglycan as a plasma membrane carrier. Trends Biochem. Sci. 28, 145-151
23. Tyagi, M., Rusnati, M., Presta, M., and Giacca, M. (2001) Internalization of HIV-1 Tat requires cell surface heparan sulfate proteoglycans. J. Biol. Chem. 276, 3254-3261
24. Silhol, M., Tyagi, M., Giacca, M., Lebleu, B., and Vives, E. (2002) Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat. Eur. J. Biochem. FEBS 269, 494-501 (Pubitemid 34128006)
25. Futaki, S., Nakase, I., Suzuki, T., Youjun, Z., and Sugiura, Y. (2002) Translocation of branched-chain arginine peptides through cell membranes: flexibility in the spatial disposition of positive charges in membrane-permeable peptides. Biochemistry 41, 7925-7930 (Pubitemid 34655157)
26. Wender, P. A., Mitchell, D. J., Pattabiraman, K., Pelkey, E. T., Steinman, L., and Rothbard, J. B. (2000) The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl. Acad. Sci. U. S. A. 97, 13003-13008
27. Howl, J., Nicholl, I. D., and Jones, S. (2007) The many futures for cell-penetrating peptides: how soon is now? Biochem. Soc. Trans. 35, 767-769 (Pubitemid 47310364)
28. Fittipaldi, A., Ferrari, A., Zoppe, M., Arcangeli, C., Pellegrini, V., Beltram, F., and Giacca, M. (2003) Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins. J. Biol. Chem. 278, 34141-34149 (Pubitemid 37553255)
29. Ferrari, A., Pellegrini, V., Arcangeli, C., Fittipaldi, A., Giacca, M., and Beltram, F. (2003) Caveolae-mediated internalization of extracellular HIV-1 Tat fusion proteins visualized in real time. Mol. Ther. 8, 284-294 (Pubitemid 37062838)
30. Vendeville, A., Rayne, F., Bonhoure, A., Bettache, N., Montcourrier, P., and Beaumelle, B. (2004) HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses. Mol. Biol. Cell 15, 2347-2360 (Pubitemid 38580651)
31. Rinne, J., Albarran, B., Jylhava, J., Ihalainen, T. O., Kankaanpaa, P., Hytonen, V. P., Stayton, P. S., Kulomaa, M. S., and Vihinen-Ranta, M. (2007) Internalization of novel non-viral vector TAT-streptavidin into human cells. BMC Bio/Tech. 7, 1
32. Wadia, J. S., Stan, R. V., and Dowdy, S. F. (2004) Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 10, 310-315 (Pubitemid 38667624)
33. Ma, M., and Nath, A. (1997) Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J. Virol. 71, 2495-2499 (Pubitemid 27078635)
34. Duchardt, F., Fotin-Mleczek, M., Schwarz, H., Fischer, R., and Brock, R. (2007) A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffic 8, 848-866 (Pubitemid 46971632)
35. Jones, A. T. (2008) Gateways and tools for drug delivery: endocytic pathways and the cellular dynamics of cell penetrating peptides. Int. J. Pharm. 354, 34-38
36. Ziegler, A., Nervi, P., Durrenberger, M., and Seelig, J. (2005) The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence. Biochemistry 44, 138-148 (Pubitemid 40095715)
37. Herce, H. D., and Garcia, A. E. (2007) Molecular dynamics simulations suggest a mechanism for translocation of the HIV-1 TAT peptide across lipid membranes. Proc. Natl. Acad. Sci. U. S. A. 104, 20805-20810
38. Bellino, S., Francavilla, V., Longo, O., Tripiciano, A., Paniccia, G., Arancio, A., Fiorelli, V., Scoglio, A., Collacchi, B., Campagna, M., Lazzarin, A., Tambussi, G., Din, C. T., Visintini, R., Narciso, P., Antinori, A., D'Offizi, G., Giulianelli, M., Carta, M., Di Carlo, A., Palamara, G., Giuliani, M., Laguardia, M. E., Monini, P., Magnani, M., Ensoli, F., and Ensoli, B. (2009) Parallel conduction of the phase I preventive and therapeutic trials based on the Tat vaccine candidate. Rev. Rec. Clin. Trials 4, 195-204
39. Wright, C. M., Felber, B. K., Paskalis, H., and Pavlakis, G. N. (1986) Expression and characterization of the trans-activator of HTLV-III/LAV virus. Science 234, 988-992 (Pubitemid 17193022)
40. Felber, B. K., and Pavlakis, G. N. (1988) A quantitative bioassay for HIV-1 based on trans-activation. Science 239, 184-187
41. Wei, X., Decker, J. M., Liu, H., Zhang, Z., Arani, R. B., Kilby, J. M., Saag, M. S., Wu, X., Shaw, G. M., and Kappes, J. C. (2002) Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob. Agents Chemother. 46, 1896-1905 (Pubitemid 34535213)
42. Derdeyn, C. A., Decker, J. M., Sfakianos, J. N., Wu, X., O'Brien, W. A., Ratner, L., Kappes, J. C., Shaw, G. M., and Hunter, E. (2000) Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J. Virol. 74, 8358-8367 (Pubitemid 30666686)
43. Platt, E. J., Wehrly, K., Kuhmann, S. E., Chesebro, B., and Kabat, D. (1998) Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J. Virol. 72, 2855-2864 (Pubitemid 28175522)
44. Major, E. O., Miller, A. E., Mourrain, P., Traub, R. G., de Widt, E., and Sever, J. (1985) Establishment of a line of human fetal glial cells that supports JC virus multiplication. Proc. Natl. Acad. Sci. U. S. A. 82, 1257-1261 (Pubitemid 15100534)
45. Li, W., Huang, Y., Reid, R., Steiner, J., Malpica-Llanos, T., Darden, T. A., Shankar, S. K., Mahadevan, A., Satishchandra, P., and Nath, A. (2008) NMDA receptor activation by HIV-Tat protein is clade dependent. J. Neurosci. 28, 12190-12198
46. Bohan, C. A., Kashanchi, F., Ensoli, B., Buonaguro, L., Boris-Lawrie, K. A., and Brady, J. N. (1992) Analysis of Tat transactivation of human immunodeficiency virus transcription in vitro. Gene Exp. 2, 391-407
47. Richard, J. P., Melikov, K., Vives, E., Ramos, C., Verbeure, B., Gait, M. J., Chernomordik, L. V., and Lebleu, B. (2003) Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 278, 585-590 (Pubitemid 36043612)
48. Green, M., and Loewenstein, P. M. (1988) Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 55, 1179-1188 (Pubitemid 19020070)
49. Fawell, S., Seery, J., Daikh, Y., Moore, C., Chen, L. L., Pepinsky, B., and Barsoum, J. (1994) Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. U. S. A. 91, 664-668 (Pubitemid 24041462)
50. Schwarze, S. R., Ho, A., Vocero-Akbani, A., and Dowdy, S. F. (1999) In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285, 1569-1572 (Pubitemid 29420581)
51. Mann, D. A., and Frankel, A. D. (1991) Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J. 10, 1733-1739 (Pubitemid 21905640)
52. Caron, N. J., Quenneville, S. P., and Tremblay, J. P. (2004) Endosome disruption enhances the functional nuclear delivery of Tat-fusion proteins. Biochem. Biophys. Res. Commun. 319, 12-20 (Pubitemid 38670154)
53. Pujals, S., Fernandez-Carneado, J., Lopez-Iglesias, C., Kogan, M. J., and Giralt, E. (2006) Mechanistic aspects of CPP-mediated intracellular drug delivery: relevance of CPP self-assembly. Biochim. Biophys. Acta 1758, 264-279 (Pubitemid 44282975)
54. Huang, L., Farhood, H., Serbina, N., Teepe, A. G., and Barsoum, J. (1995) Endosomolytic activity of cationic liposomes enhances the delivery of human immunodeficiency virus-1 trans-activator protein (TAT) to mammalian cells. Biochem. Biophys. Res. Commun. 217, 761-768
55. Fong, S. E., Smanik, P., Smith, M. C., and Jaskunas, S. R. (1997) Cationic liposome-mediated uptake of human immunodeficiency virus type 1 Tat protein into cells. J. Virol. Methods 66, 149-157 (Pubitemid 27293937)
56. Nabi, I. R., and Le, P. U. (2003) Caveolae/raft-dependent endocytosis. J. Cell Biol. 161, 673-677 (Pubitemid 36648749)
57. Nichols, B. (2003) Caveosomes and endocytosis of lipid rafts. J. Cell Sci. 116, 4707-4714
58. Parton, R. G., and Richards, A. A. (2003) Lipid rafts and caveolae as portals for endocytosis: new insights and common mechanisms. Traffic 4, 724-738 (Pubitemid 37361854)
59. Kirkham, M., and Parton, R. G. (2005) Clathrin-independent endocytosis: new insights into caveolae and non-caveolar lipid raft carriers. Biochim. Biophys. Acta 1746, 349-363
60. Lajoie, P., and Nabi, I. R. (2007) Regulation of raft-dependent endocytosis. J. Cell. Mol. Med. 11, 644-653 (Pubitemid 47313313)
61. Mayor, S., and Pagano, R. E. (2007) Pathways of clathrin-independent endocytosis. Nat. Rev. 8, 603-612 (Pubitemid 47106613)
62. Yezid, H., Konate, K., Debaisieux, S., Bonhoure, A., and Beaumelle, B. (2009) Mechanism for HIV-1 Tat insertion into the endosome membrane. J. Biol. Chem. 284, 22736-22746
63. Zhou, X., and Huang, L. (1994) DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action. Biochim. Biophys. Acta 1189, 195-203 (Pubitemid 24042719)
64. Farhood, H., Serbina, N., and Huang, L. (1995) The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim. Biophys. Acta 1235, 289-295
65. Hoekstra, D., Rejman, J., Wasungu, L., Shi, F., and Zuhorn, I. (2007) Gene delivery by cationic lipids: in and out of an endosome. Biochem. Soc. Trans. 35, 68-71
66. Chen, D., Wang, M., Zhou, S., and Zhou, Q. (2002) HIV-1 Tat targets microtubules to induce apoptosis, a process promoted by the pro-apoptotic Bcl-2 relative Bim. EMBO J. 21, 6801-6810 (Pubitemid 36014552)
67. Ross, J. L., Ali, M. Y., and Warshaw, D. M. (2008) Cargo transport: molecular motors navigate a complex cytoskeleton. Curr. Opin. Cell Biol. 20, 41-47
68. Rusnati, M., Tulipano, G., Spillmann, D., Tanghetti, E., Oreste, P., Zoppetti, G., Giacca, M., and Presta, M. (1999) Multiple interactions of HIV-I Tat protein with size-defined heparin oligosaccharides. J. Biol. Chem. 274, 28198-28205
69. Torchilin, V. P., Rammohan, R., Weissig, V., and Levchenko, T. S. (2001) TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc. Natl. Acad. Sci. U. S. A. 98, 8786-8791 (Pubitemid 32678105)
70. Torchilin, V. P., Levchenko, T. S., Rammohan, R., Volodina, N., Papahadjopoulos-Sternberg, B., and D'Souza, G. G. (2003) Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes. Proc. Natl. Acad. Sci. U. S. A. 100, 1972-1977 (Pubitemid 36254558)
71. Pappalardo, J. S., Quattrocchi, V., Langellotti, C., Di Giacomo, S., Gnazzo, V., Olivera, V., Calamante, G., Zamorano, P. I., Levchenko, T. S., and Torchilin, V. P. (2009) Improved transfection of spleen-derived antigen-presenting cells in culture using TATp-liposomes. J. Control. Release 134, 41-46
72. Bhattacharyya, R., Pal, D., and Chakrabarti, P. (2004) Disulfide bonds, their stereospecific environment and conservation in protein structures. Protein Eng. Des. Sel. 17, 795-808 (Pubitemid 40313673)
73. Rapoport, M., and Lorberboum-Galski, H. (2009) TAT-based drug delivery system-new directions in protein delivery for new hopes? Expert Opin. Drug Deliv. 6, 453-463